Abstract: The present invention relates to a system (100) for detecting respiratory gas components, comprising a respiratory gas inlet (101), a measuring cell (103) connected to the respiratory gas inlet (101) with at least one respiratory gas sensor, a gas outlet (105) downstream of the measuring cell (103), a data processing unit connected to the measuring cell (103), an energy supply (107), characterized in that the system (100) has an additional sensor (109) for measuring at least the carbon dioxide content of the ambient air of the system (100).

Abstract: The present invention relates to a body carrier system for a mobile device, comprising a vest-like carrying element, a back part, two shoulder straps connected to the back part and a hip belt connected to the back part, and a two-part holding element for the mobile measuring device, whose both sub-elements can be reversibly fixed to the vest-like carrying element, as well as reversibly connected to each other, wherein each shoulder strap is equipped with welts in the front and/or wherein spaced welts are provided on the back part of the vest-like carrying element, and wherein on each of the two sub-elements of the two-part holding element welt guides are provided, so that the welt guides can be engaged with the welts.

Abstract: A hot-melt adhesive composition, which can be used for bonding of expanded polystyrene foam plates and expanded extruded polystyrene foam plates. The adhesive composition includes at least one at 25° C. solid poly-?-olefin, at least one tackifying resin, and at least one organic phosphorus-containing compound. The invention also uses adhesive composition for bonding of plastic foam plates, to a method for producing a composite element, and to a composite element including a first and second substrate bonded to each via a layer of adhesive composition of the present invention.

Abstract: The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer.

Abstract: The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer.

Abstract: The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer.

Abstract: The present invention relates to a Statistical method of assessing whether a subject suffers from Cancer or is prone to suffering from Cancer, said method comprising the step of performing at least one Statistical algorithm for Classification and for regression on measurement data of the subject, wherein the measurement data of the subject comprises at least one of the following: a value of GATA6 Em isoform in at least one sample taken from the subject, a value NKX2-1 Em isoform in said at least one sample, a value of GATA6 Ad isoform in said at least one sample, NKX2-1 Ad isoform in said at least one sample; and wherein at least one of the following is used as at least one classifier or a component of at least one classifier in the Statistical method: GATA6 Em isoform, NKX2-1 Em isoform, GATA6 Ad isoform, NKX2-1 Ad isoform, ratio of GATA6 Em isoform/GATA6 Ad isoform, ratio of NKX2-1 Em isoform/NKX2-1 Ad isoform.

Abstract: Disclosed is a sealing device for sealing at least one first volume of an arrangement for the treatment of at least one medical fluid against at least one second volume, wherein the first volume is provided for receiving at least one external functional device. The sealing device includes at least one first connection device whereby the sealing device may be connected to the arrangement. In addition an arrangement and a method are disclosed.

Abstract: An external functional means comprises at least one housing body, at least one chamber integrated into the housing body for receiving medical fluids, at least one passage integrated into the housing body for receiving and/or conducting a medical fluid, and at least one valve means completely or partly integrated into the housing body for controlling or regulating a fluid flowing through the external functional means. The invention further specifies a blood treatment apparatus and methods which may be carried out by means of the external functional means of the invention and by means of the blood treatment apparatus, respectively.

Abstract: The present invention relates to a device and a method for blood treatment in a single-needle operating mode. The blood treatment device has an extracorporeal blood circuit comprising a blood supply line leading to the inlet of a blood treatment unit and a blood return line leading away from the outlet of the blood treatment unit. Blood collecting means, for example a blood collecting container, is provided in the blood return line, said means being connected to means for storing gas, for example an air reservoir, by a flow line. The flow connection comprises two line branches, one branch being used to transfer gas from the air reservoir into the blood collecting container and the other branch being used to transfer gas from the blood collecting container into the air reservoir. The connection branch for transferring gas from the air store into the blood collecting container contains means for compressing air, for example a compressor.

Abstract: The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer.

Abstract: An RFID reading apparatus (10) is provided for reading RFID transponders (22) in a reading zone (24) in accordance with an RFID protocol, the RFID reading apparatus having an antenna (16, 26), a receiver (12, 18) for receiving RFID signals of the RFID transponders (22) with the aid of the antenna (16, 26) and an evaluation unit (12, 18) for reading a piece of RFID information from the received RFID signals, wherein the antenna (16, 28) is an external antenna (16) connected via a line (14) and has a display element (30) and/or has an operating element (32) which can be controlled by the evaluation unit (12, 18). In this respect, the external antenna (16) has a communication unit (28) for controlling the display element (30) and/or the operating element (32); and wherein the communication unit (28) is configured to communicate with the evaluation unit (12, 18) via the line (14) in accordance with the RFID protocol.

Abstract: An apparatus for treating a medical liquid includes a treatment machine having a coupling surface and a flexible mat arranged on the coupling surface, with a cassette made of a hard part having liquid-conducting passages therein which are covered by a flexible film that is couplable to the coupling surface of the treatment machine via the flexible mat. The apparatus includes an element for monitoring a fault-free coupling to the cassette at the coupling surface by determining a difference of the pressure between the cassette and the flexible mat and the pressure between the flexible mat and the coupling surface. A method for checking the leak tightness of the fault-free coupling employs the apparatus.

Abstract: The present invention relates to a device and a method for blood treatment in a single-needle operating mode. The blood treatment device has an extracorporeal blood circuit comprising a blood supply line leading to the inlet of a blood treatment unit and a blood return line leading away from the outlet of the blood treatment unit. Blood collecting means, for example a blood collecting container, is provided in the blood return line, said means being connected to means for storing gas, for example an air reservoir, by a flow line. The flow connection comprises two line branches, one branch being used to transfer gas from the air reservoir into the blood collecting container and the other branch being used to transfer gas from the blood collecting container into the air reservoir. The connection branch for transferring gas from the air store into the blood collecting container contains means for compressing air, for example a compressor.

Abstract: The invention relates to an RFID reading apparatus arranged stationary at a conveyor device. The RFID information is read in that during a reading procedure a transponder signal is generated for which purpose an RFID information of a frequency in a base band is modulated by back-scatter modulation onto a carrier signal. In accordance with the invention the transmitter unit has two transmitting antennae spaced apart in the conveying direction with the transmitter signal of one transmission antenna representing the in-phase component of the quadrature amplitude modulated transmission signal and the transmitter signal of the other transmission antenna representing the quadrature component of the quadrature amplitude modulated transmission signal so that on transmission of the in-phase and quadrature components these are superimposed in a plane extending transverse to the conveyor device additively to the full quadrature amplitude modulated transmitter signal.

Abstract: The present invention relates to recombinant chimeric proteins comprising a surfactant protein precursor N-terminally fused to a plasminogen activator or comprising a mature surfactant protein N-terminally or C-terminally fused to a plasminogen activator. The invention is also directed to the corresponding nucleic acid molecules encoding such fusion proteins as well as to a method for their production. The invention further refers to a pharmaceutical composition comprising such a fusion protein and to pharmacological uses of an inventive fusion protein for the prevention and/or treatment of inflammatory and interstitial lung diseases.

Abstract: An RFID reading apparatus (10) is provided for stationary mounting at a reading zone (18) of a conveyor (12) or of a reading portal (40) for reading out at least one RFID transponder (22) moved on the conveyor (12) or through the reading portal (40), having a receiver (32) and a plurality of antennas (24, 26) connected to the receiver (32) for receiving RFID signals from the RFID transponder (22) as well as having an evaluation unit (36) for reading out RFID information from the received RFID signals, wherein the RFID reading apparatus (10) includes a first housing (28) in which the receiver (32) and the evaluation unit (36) are accommodated. In this respect, one of the antennas is an internal antenna (24) which is mechanically fastened to the first housing (28) and another of the antennas (28) is an external antenna.

Abstract: The invention relates to an optical range finder comprising a light transmitter for the transmission of measurement light into a monitored space, a light receiver for the reception of measurement light reflected or remitted by an object in the monitored space, and an evaluation circuit to determine the time of flight of the measurement light from the output signal and to determine the distance of the object therefrom. In accordance with the invention, a PIN diode circuit is provided between the light receiver and the evaluation circuit and is electrically connected to them, with the PIN diode circuit damping the current output signal of the light receiver. The invention furthermore relates to an optical range finding method which can be carried out with the optical range finder in accordance with the invention.

Abstract: The invention relates to a new, advantageous method for the preparation of dialkyl ?-fluoromalonates.

Abstract: The present invention relates to recombinant chimeric proteins comprising a surfactant protein precursor N-terminally fused to a plasminogen activator or comprising a mature surfactant protein N-terminally or C-terminally fused to a plasminogen activator. The invention is also directed to the corresponding nucleic acid molecules encoding such fusion proteins as well as to a method for their production. The invention further refers to a pharmaceutical composition comprising such a fusion protein and to pharmacological uses of an inventive fusion protein for the prevention and/or treatment of inflammatory and interstitial lung diseases.